START Cancer Research New York-Long Island — Lake Success, New York

START Cancer Research New York-Long Island is a clinical research site located in Lake Success, New York, United States 11042.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

START Cancer Research New York-Long Island has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer.

Sponsors: Aminex Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Cancer Research New York-Long Island?

START Cancer Research New York-Long Island has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Cancer Research New York-Long Island conducted?

START Cancer Research New York-Long Island has 1 clinical trials on record, with 1 currently active. Their work covers Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer.

Is START Cancer Research New York-Long Island accredited by Crixeo Health?

START Cancer Research New York-Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Cancer Research New York-Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.